Article ID Journal Published Year Pages File Type
4003024 American Journal of Ophthalmology 2012 9 Pages PDF
Abstract
Recommendations arising from a root cause analysis of infectious endophthalmitis outbreaks should focus on the procedures used by pharmacies to compound bevacizumab. Microbial contamination of bevacizumab-containing syringes prepared from the same vial of drug can be avoided by using a single vial of bevacizumab for each eye or by following strict adherence to United States Pharmacopoeia Chapter 797 requirements when compounding a single vial of bevacizumab into multiple syringes.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , ,